Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease (AD)”

660 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 660 results

Not applicableStudy completedNCT02409082
What this trial is testing

Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures

Who this might be right for
Alzheimers DiseaseInflammationHip Fracture
Sahlgrenska University Hospital 400
Early research (Phase 1)Study completedNCT02187627
What this trial is testing

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Who this might be right for
Alzheimer's Disease, Healthy Volunteer
Hoffmann-La Roche 52
Not applicableStudy completedNCT03221296
What this trial is testing

Fall Prevention - Vestibular Rehabilitation

Who this might be right for
Alzheimer Dementia (AD)Vascular Dementia
University Health Network, Toronto 29
Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Post-approval studies (Phase 4)Study completedNCT01585272
What this trial is testing

Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia

Who this might be right for
Alzheimer's Dementia
Novartis Pharmaceuticals 121
Not applicableLooking for participantsNCT02740634
What this trial is testing

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Who this might be right for
Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more
Mayo Clinic 60
Not applicableStudy completedNCT00908999
What this trial is testing

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Who this might be right for
AnosognosiaAlzheimer's DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 60
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Post-approval studies (Phase 4)Study completedNCT01122329
What this trial is testing

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, Los Angeles 17
Very early researchStudy completedNCT03080051
What this trial is testing

Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Who this might be right for
Progressive Supranuclear PalsyAlzheimer DiseaseHealthy Volunteers
Molecular NeuroImaging 6
Large-scale testing (Phase 3)Active Not RecruitingNCT06709014
What this trial is testing

Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who this might be right for
Early Alzheimers Disease
Annovis Bio Inc. 760
Early research (Phase 1)Study completedNCT03802162
What this trial is testing

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Who this might be right for
Alzheimer's Disease (AD)
Chong Kun Dang Pharmaceutical 60
Large-scale testing (Phase 3)Ended earlyNCT04339413
What this trial is testing

Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 116
Early research (Phase 1)Looking for participantsNCT07218081
What this trial is testing

A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.

Who this might be right for
Alzheimer Dementia (AD)
Augusta University 12
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Not applicableLooking for participantsNCT07341009
What this trial is testing

Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Time Perception
University Hospital, Caen 40
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Early research (Phase 1)Study completedNCT05827653
What this trial is testing

MAD Study of NX210c

Who this might be right for
Healthy Elderly
Axoltis Pharma 29
Testing effectiveness (Phase 2)Study completedNCT01998841
What this trial is testing

Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 252
Not applicableNot Yet RecruitingNCT07105956
What this trial is testing

Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease (AD)
Nanjing First Hospital, Nanjing Medical University 8
Next Page